Skip to main content

Day: November 6, 2025

Ming Shing Group Holdings Limited Announces Resignation of Director and Addition to Board of Directors

Hong Kong, Nov. 06, 2025 (GLOBE NEWSWIRE) — Ming Shing Group Holdings Limited (the “Company” or “Ming Shing”) (NASDAQ: MSW), a Hong Kong-based company mainly engaged in wet trades works whose mission it is to become the leading wet trades works service provider in Hong Kong, announces a significant update in its board of directors (the “Board of Directors”). Ming Shing announces the resignation of Yu Yuan as an independent director. Mr. Yuan has indicated his resignation is for personal reasons and not due to any disagreement with the Company. Ming Shing is pleased to announce the appointment of Wan-Jung Sun to its Board of Directors as director of the Company. Ms. Sun, age 39, has over 10 years of experience in business administration. Her expertise will be pivotal to Ming Shing’s future business development. “We are thankful...

Continue reading

Disclosure of total number of voting rights and number of shares forming the capital as of October 31, 2025

Disclosure of total number of voting rights andnumber of shares forming the capitalas of October 31, 2025 Clichy, France – November 06, 2025 Article L 233-8-II of the French “Code de Commerce” and Article 223-16 of the General Regulations of the French “Autorité des Marchés Financiers”. As of October 31, 2025, the total number of issued shares of SOCIÉTÉ BIC is 41,621,162 shares, representing:–        58,357,733 voting rights,–        57,750,137 voting rights excluding shares without voting rights ContactsBrice ParisVP Investor Relations +33 6 42 87 54 73brice.paris@bicworld.com   Investor Relationsinvestors.info@bicworld.com       Bethridge ToovellVP Global Communications+1 917 821 4249bethridge.toovell@bicworld.com   Isabelle de Segonzac Image 7, Press Relations contact+33 6 89 87 61 39isegonzac@image7.fr  Agenda All...

Continue reading

Akwel: Nine-Month Revenue Down -3.6%

        Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M, down -3.6% compared to the same period in 2024. Consolidated revenue (from January 1 to September 30, 2025)in €m — unaudited 2025 2024 Variation PCC variation (1)1st quarter 255.6 263.5 -3.0% -4.0%2nd quarter 255.0 265.3 -3.9% -2.7%3rd quarter 220.1 228.9 -3.9% -2.0%Nine-month total 730.7 757.7 -3.6% -3.0%(1)   At constant scope and exchange rates. DECREASE OF -3.9% IN THIRD-QUARTER REVENUE With consolidated revenue of €220.1M in the third quarter...

Continue reading

Akwel: Nine-month revenue down -3.6%

        Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M. Consolidated revenue (from January 1 to September 30, 2025)in €m — unaudited 2025 2024 Variation PCC variation (1)1st quarter 255.6 263.5 -3.0% -4.0%2nd quarter 255.0 265.3 -3.9% -2.7%3rd quarter 220.1 228.9 -3.9% -2.0%Nine-month total 730.7 757.7 -3.6% -3.0%(1)   At constant scope and exchange rates. In the third quarter of the year, AKWEL recorded a decline in reported activity of -3.9%, which is comparable to previous quarters, and -2.0% at constant...

Continue reading

Euronext publishes Q3 2025 results and announces a share repurchase programme

Euronext publishes Q3 2025 results and announces a share repurchase programme Euronext has delivered the sixth consecutive quarter of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading and clearing revenues and continued cost discipline. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 6 November 2025 – Euronext, the leading European capital market infrastructure, today publishes its results for the third quarter of 2025.Q3 2025 revenue and income was up +10.6%1 to €438.1 million:Non-volume-related revenue and income represented 60% of total revenue and income and covered 162% of underlying operating expenses, excluding D&A2:Securities Services revenues grew to €77.3 million (+6.0%), driven by double-digit revenue growth in custody and settlement, supported by sustainable...

Continue reading

Q3 2025 Operational & Financial Results and Progress Report on Key Developments to Double Production by 2030

TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — McEwen Inc. (NYSE/TSX: MUX) today announced its third quarter (Q3) and year-to-date (9M) results for the period ended September 30, 2025, and reported on its plan to double production by 2030, lower costs, and extend mine life across all operations. Management believes these initiatives provide an achievable path toward our goal of 250,000 to 300,000 GEOs Consolidated Annual Production by 2030. McEwen is advancing the following projects: The Fox Complex (Stock and Grey Fox) is expected to contribute approximately 50% of the total production goal. This will be followed by the Gold Bar Mine Complex (Gold Bar Mine, Windfall and Lookout Mountain) at 30%, and El Gallo (Phases 1 and 2) at 20%. The acquisition of Canadian Gold Corp’s Tartan mine is excluded from this forecast.Stock Mine...

Continue reading

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progression Bilateral kidney injection with rilparencel resulted in a 4.6 mL/min/1.73m2 (78%) improvement in the annual decline of estimated glomerular filtration rate (eGFR) slope in Group 1 (n=24) patients No rilparencel-related serious adverse events were observed; the overall study safety profile was consistent with previously reported study results and comparable to a kidney biopsy FDA previously confirmed eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel More than half of the patients required for the Phase 3 REGEN-006 (PROACT 1) accelerated approval analysis using eGFR slope have been enrolled; topline results anticipated...

Continue reading

Xtreme One Entertainment Adds Football to its Sports Platform, Announces Letter of Intent to Acquire The 7on7 Association

GRAND RAPIDS, Mich. and SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) — Xtreme One Entertainment, Inc. (OTCPink: XONI), a leading innovator in live sports and entertainment and the parent company of Xtreme Fighting Championships (XFC), today announced it has signed a Letter of Intent (“LOI”) to acquire The 7on7 Association, the nation’s fastest-growing youth football league redefining the future of competitive and development-level football. The proposed acquisition represents a significant milestone in Xtreme One’s multi-sport expansion strategy, positioning the company to capitalize on the synergies of live sports, media monetization, and digital fan engagement. Through strategic mergers and acquisitions, Xtreme One is building a next-generation entertainment ecosystem that leverages its event operations, media distribution, and sponsorship...

Continue reading

Ensurge Micropower ASA – Q3 2025

Highlights Shauna McIntyre appointed new CEO of Ensurge Micropower ASA.  New Board of Directors, including the election of Alex Munch-Thore as new Chairman of the Board.  Signed Joint Development Agreement with Corning, a Fortune 500 industry-leading innovator in glass, ceramics, and materials science.  Signed Investment Agreement with Corning, benefiting from full-time Corning resources on-site at Ensurge to support ongoing development of ultra-high performance product line extension using Corning’s Ribbon Ceramic substrate.  Successfully shipped numerous battery prototypes as fulfillment toward evaluation agreements  Improved manufacturing throughput, quality and repeatability including roll-to-roll (R2R) cell layer manufacturing and battery cell assembly.  Progressing multi-year paid development programs across medical and consumer...

Continue reading

American Battery Technology Company Selected to Recycle Batteries from the Largest Lithium-Ion Battery Cleanup in US History, $30 Million Estimated Project Proceeds

Projects involve safe processing of wide variety of damaged battery materials through the company’s internally-developed recycling processes and the sale of recycled critical mineral products back into the battery supply chain Reno, Nev., Nov. 06, 2025 (GLOBE NEWSWIRE) — American Battery Technology Company (NASDAQ: ABAT), an integrated critical battery materials company commercializing both its primary battery critical mineral manufacturing and secondary lithium-ion battery recycling facilities, has been contracted for and approved by the U.S. Environmental Protection Agency (EPA) to recycle the end-of-life lithium-ion batteries from the largest lithium-ion battery cleanup operation in EPA history. The project’s focus is on the safe handling and processing of damaged battery materials, underscoring the company’s commitment to protecting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.